ESTAEstablishment Labs Holdings Inc.

$2B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M+28.7% YoY

Gross Profit

$27M66.7% margin

Operating Income

-$10M-25.3% margin

Net Income

-$37M-90.1% margin

EPS (Diluted)

$-1.52

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$25M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$200M

Total Liabilities

$184M

Stockholders' Equity

$16M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$32M	+28.7%
Gross Profit	$27M	$21M	+27.9%
Operating Income	-$10M	-$5M	-124.6%
Net Income	-$37M	-$5M	-597.2%

Geographic Segments

Latin America

$14M34%

Asia Pacific And Middle East

$13M33%

Europe

$13M32%

Other Geographical Areas

$232,0001%

ESTA Q2 2022 Earnings — Establishment Labs Holdings Inc. Revenue & Financial Results | Market Cap Arena